Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors

Sodium glucose cotransporter 2 inhibitors (SGLT2i) block the reabsorption of glucose by inhibiting SGLT2, thus improving glucose control by promoting the renal excretion of glucose, without requiring insulin secretion. This pharmacological property of SGLT2i reduces body weight and improves insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanai, Hidekatsu, Hakoshima, Mariko, Adachi, Hiroki, Katsuyama, Hisayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122906/
https://www.ncbi.nlm.nih.gov/pubmed/33922546
http://dx.doi.org/10.3390/ijms22094416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122906/
https://www.ncbi.nlm.nih.gov/pubmed/33922546
http://dx.doi.org/10.3390/ijms22094416

Ejemplares similares